IN SB 157
died on adjournmentDisclosures related to prescription drugs.
Indiana · 2026 Regular Session (2nd Regular Session, 124th General Assembly) · upper
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did IN SB 157 pass?
No. IN SB 157 died when the 2026 Regular Session (2nd Regular Session, 124th General Assembly) adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-01-28): First reading: referred to Committee on Public Health
What is IN SB 157 about?
Requires certain pharmacists or pharmacies to provide the amount of the national average drug acquisition cost for a generic drug on the written materials provided to an individual at the point of sale of the generic drug.
Who sponsors IN SB 157?
Lori Goss-Reaves, Michael Crider, Mike Bohacek are the primary sponsors of IN SB 157, joined by 3 cosponsors.
Description
Requires certain pharmacists or pharmacies to provide the amount of the national average drug acquisition cost for a generic drug on the written materials provided to an individual at the point of sale of the generic drug.
- Introduced
- —
- Latest action
- 2026-01-28 — First reading: referred to Committee on Public Health
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Lori Goss-Reavessponsor
- Michael Criderauthor
- Mike Bohacekauthor
- Brad Barrettcosponsor
- Lonnie Randolphcoauthor
- La Keisha Jacksoncoauthor
Committees
Not provided by source.
Action timeline
Newest first
2026-01-28
First reading: referred to Committee on Public Health
reading-1,referral-committee
2026-01-27
Referred to the House
referral
2026-01-26
Cosponsor: Representative Barrett
2026-01-26
House sponsor: Representative Goss-Reaves
2026-01-26
Senator Crider added as second author
2026-01-26
Third reading: passed; Roll Call 72: yeas 44, nays 0
passage,reading-3,reading-3
2026-01-22
Amendment #1 (Bohacek) prevailed; voice vote
amendment-passage
2026-01-22
Second reading: amended, ordered engrossed
reading-2
2026-01-15
Committee report: amend do pass, adopted
committee-passage
2026-01-15
Senator Randolph added as coauthor
2026-01-06
Senator Jackson L added as coauthor
2026-01-05
Authored by Senator Bohacek
2026-01-05
First reading: referred to Committee on Insurance and Financial Institutions
reading-1,referral-committee
Versions
Documents
- application/pdf
- application/pdf
- application/pdf
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
Votes
SB 157 - Bohacek - 3rd Reading
2026-01-26 · pass · 44-0
Member-level votes (49)
- Alexander: yes
- Charbonneau: yes
- Goode: yes
- Qaddoura: yes
- Alting: yes
- Clark: yes
- Holdman: yes
- Raatz: yes
- Baldwin: yes
- Crider: yes
- Hunley: yes
- Rogers: yes
- Bohacek: yes
- Deery: yes
- Johnson: yes
- Schmitt: yes
- Bray: yes
- Dernulc: yes
- Koch: yes
- Spencer: yes
- Brown: yes
- Donato: yes
- Leising: yes
- Taylor: yes
- Buchanan: yes
- Doriot: yes
- Maxwell: yes
- Tomes: yes
- Buck: yes
- Freeman: yes
- Mishler: yes
- Walker G: yes
- Busch: yes
- Garten: yes
- Niemeyer: yes
- Walker K: yes
- Byrne: yes
- Gaskill: yes
- Niezgodski: yes
- Yoder: yes
- Carrasco: yes
- Glick: yes
- Pol: yes
- Young: yes
- Bassler: excused
- Ford J.D.: excused
- Jackson, L: excused
- Randolph: excused
- Becker: excused
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:22:09.317128Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=IN&identifier=SB 157. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
- Some documents have no extracted text yet, so version comparison may be limited.
See the methodology page for data sources and limitations.